[Peri-ictal SPECT in temporal lobe epilepsy: post-surgical evaluation]. / SPECT periictal en la epilepsia del lóbulo temporal: valoración tras cirugía.

INTRODUCTION: our aim was to evaluate the usefulness of peri-ictal SPECT in localising the epileptogenic region (ER) in candidates for temporal lobectomy to treat medically refractory complex partial seizures (CPS). Interictal and ictal SPECT, MRI and video-EEG results were compared and the positive predictive value (PPV) was calculated in those patients with good surgical outcome. MATERIALS AND METHODS: 37 patients who had a minimum of 3 years follow-up after surgery were studied retrospectively. Pre-surgical evaluation had included video-EEG monitoring, MRI and interictal and ictal SPECT. These results were compared to the surgically treated ER and successful outcome confirmed by post-surgical clinical follow-up. 29/37 patients remained seizure-free in the post-surgical follow-up. Interictal and peri-ictal SPECT were performed using 740 MBq of 99mTc-HMPAO. Peri-ictal SPECT was ictal in 25 patients and postictal in 12. RESULTS: ER concordance with video-EEG and peri-ictal SPECT was 86% (32/37 patients). It was 84% (31/37) for MRI and 54% (20/37 patients) for interictal SPECT. Peri-ictal SPECT localised the ER in 8/11 patients with discordant MRI and video-EEG results. Ictal SPECT localised the ER in the correct temporal lobe in 23/25 patients (92% concordance). In the 29 patients with a good surgical outcome, the PPV of video-EEG was 95% (27/29) and it was 90% (26/29) for both MRI and peri-ictal SPECT. CONCLUSIONS: peri-ictal brain SPECT is well able to localize ER in patients with temporal lobe epilepsy. Periictal SPECT concordance with ER was as good as video-EEG and MRI and its PPV was as good as that of MRI. We strongly recommend its use in the pre-surgical evaluation of temporal lobe epilepsy, especially when MRI and EEG are discordant.

SPECT periictal en la epilepsia del lóbulo temporal: valoración tras cirugía / Peri-ictal SPECT in temporal lobe epilepsy: post-surgical evaluation

Introducción: el objetivo de este trabajo fue valorar la utilidad de la tomografía computarizada por emisión monofotónica (SPECT) periictal para localizar la región epileptógena (RE) en pacientes con crisis parciales complejas (CPC) del lóbulo temporal. Material y métodos: de forma retrospectiva se ha evaluado a 37 pacientes con CPC del lóbulo temporal a quienes se realizó una lobectomía temporal completa o selectiva. Para ello, se comparó la concordancia de la RE quirúrgica con los hallazgos de la resonancia magnética (RM), el videoelectroencefalograma (vídeo-EEG) y las SPECT cerebrales interictal y periictal. En segundo lugar, se valoró el valor predictivo positivo (VPP) de estas exploraciones en los 29 pacientes que presentaron un buen control de las crisis tras la cirugía. La SPECT se realizó tras la inyección de 740 MBq de 99mTc-HMPAO. Resultados: la concordancia de la RE quirúrgica con el vídeo-EEG, la RM, la SPECT icterictal y la SPECT periictal fue del 86% (32/37 pacientes), el 84% (31/37 pacientes), el 54% (20/37 pacientes) y el 86% (32/37 pacientes), respectivamente. En los 11 casos con RM y vídeo-EEG discordante o normal, la SPECT periictal fue decisivo en 8 (73%). En los 29 pacientes con evolución favorable tras la cirugía, el VPP del vídeo-EEG fue del 95% (27/29) y el de la RM y la SPECT periictal fue del 90% (26/29). Conclusiones: la concordancia de la RE quirúrgica con la SPECT periictal fue similar al del vídeo-EEG y la RM y tuvo el mismo VPP que la RM. Por ello, creemos que la SPECT periictal debe emplearse de forma sistemática en la evaluación prequirúrgica de la epilepsia del lóbulo temporal, especialmente cuando vídeo-EEG y RM son discordantes o normales(AU)

Introduction: our aim was to evaluate the usefulness of peri-ictal SPECT in localising the epileptogenic region (ER) in candidates for temporal lobectomy to treat medically refractory complex partial seizures (CPS). Interictal and ictal SPECT, MRI and video-EEG results were compared and the positive predictive value (PPV) was calculated in those patients with good surgical outcome. Materials and methods: 37 patients who had a minimum of 3 years follow-up after surgery were studied retrospectively. Pre-surgical evaluation had included video-EEG monitoring, MRI and interictal and ictal SPECT. These results were compared to the surgically treated ER and successful outcome confirmed by post-surgical clinical follow-up. 29/37 patients remained seizure-free in the post-surgical follow-up. Interictal and peri-ictal SPECT were performed using 740 MBq of 99mTc-HMPAO. Peri-ictal SPECT was ictal in 25 patients and postictal in 12. Results: ER concordance with video-EEG and peri-ictal SPECT was 86% (32/37 patients). It was 84% (31/37) for MRI and 54% (20/37 patients) for interictal SPECT. Peri-ictal SPECT localised the ER in 8/11 patients with discordant MRI and video-EEG results. Ictal SPECT localised the ER in the correct temporal lobe in 23/25 patients (92% concordance). In the 29 patients with a good surgical outcome, the PPV of video-EEG was 95% (27/29) and it was 90% (26/29) for both MRI and peri-ictal SPECT. Conclusions: peri-ictal brain SPECT is well able to localize ER in patients with temporal lobe epilepsy. Periictal SPECT concordance with ER was as good as video-EEG and MRI and its PPV was as good as that of MRI. We strongly recommend its use in the pre-surgical evaluation of temporal lobe epilepsy, especially when MRI and EEG are discordant(AU)

[Usefulness of bone scintigraphy for staging in a case of histiocytosis of the temporal bone]. / La gammagrafía ósea demuestra ser útil para el diagnóstico de extensión en un caso de histiocitosis X del hueso temporal.

We present the case of a 43-year-old man diagnosed of insipid diabetes and hypogonadotropic hypogonadism in whom a right temporal bone lesion was observed in the control MRI, thus leading to his admission. A bone scintigraphy with 99mTc-HMDP showed increased uptake in the right temporal region with sphenoidal extension, coinciding with the MRI. In addition, increased uptake having less intensity and size was observed in the left temporal region. A biopsy on the newly appearing mouth ulcers in the jugal mucous was performed and showed Langerhan's cells, the diagnosis of histiocytosis X being confirmed. Six months later a new MRI indicated disease progression with bilateral temporal involvement. The bone scan findings in this case provided a more exact extension diagnosis of the disease than the MRI.

La gammagrafía ósea demuestra ser útil para el diagnóstico de extensión en un caso de histiocitosis X del hueso temporal / Usefulness of bone scintigraphy for staging in a case of histiocytosis od the temporal bone

Exponemos el caso de un varón de 43 años diagnosticado de diabetes insípida e hipogonadismo hipogonadotropo, que en la RM craneal de control se objetivó una lesión extraaxial temporal derecha, motivo por el que fue ingresado. Se realizó una gammagrafía ósea que describió un aumento de captación de Tc99m-HMDP en región temporal derecha con extensión esfenoidal, coincidente con la RM. Además, en región temporal izquierda se observó una hipercaptación de menor intensidad y tamaño. Se realizó biopsia sobre úlceras bucales de nueva aparición en mucosa yugal que mostró células de Langerhans, estableciéndose el diagnóstico de histiocitosis X. Al cabo de 6 meses se realizó una nueva RM que demostró progresión de la enfermedad, con afectación temporal bilateral. Los hallazgos de la gammagrafía ósea, dieron lugar en este caso a un diagnóstico de extensión de la enfermedad más preciso que la RM

We present the case of a 43-year-old man diagnosed of insipid diabetes and hypogonadotropic hypogonadism in whom a right temporal bone lesion was observed in the control MRI, thus leading to his admission. A bone scintigraphy with 99mTc-HMDP showed increased uptake in the right temporal region with sphenoidal extension, coinciding with the MRI. In addition, increased uptake having less intensity and size was observed in the left temporal region. A biopsy on the newly appearing mouth ulcers in the jugal mucous was performed and showed Langerhan's cells, the diagnosis of Histiocytosis X being confirmed. Six months later a new MRI indicated disease progression with bilateral temporal involvement. The bone scan findings in this case provided a more exact extension diagnosis of the disease than the MRIWe present the case of a 43-year-old man diagnosed of insipid diabetes and hypogonadotropic hypogonadism in whom a right temporal bone lesion was observed in the control MRI, thus leading to his admission. A bone scintigraphy with 99mTc-HMDP showed increased uptake in the right temporal region with sphenoidal extension, coinciding with the MRI. In addition, increased uptake having less intensity and size was observed in the left temporal region. A biopsy on the newly appearing mouth ulcers in the jugal mucous was performed and showed Langerhan's cells, the diagnosis of Histiocytosis X being confirmed. Six months later a new MRI indicated disease progression with bilateral temporal involvement. The bone scan findings in this case provided a more exact extension diagnosis of the disease than the MRI

Utilidad de la pilocarpina como profiláctico de xerostomía en pacientes con cáncer de cabeza y cuello tratados con radioterapia. Valoración mediante gammagrafía y flujo salivar / Utility of pilocarpine evaluated by salivary gland scintigraphy and salivary flow in the treatment of radiation-induced xerostomia in head and neck cancer patients

Objetivo: Estudiar la utilidad de la pilocarpina para prevenir la xerostomía en pacientes con cáncer de cabeza y cuello que han sido tratados con radioterapia (RDT), utilizando como métodos de medida la sialometría y la gammagrafía salivar. Material y métodos: Se incluyeron 32 pacientes con cáncer de cabeza y cuello tratados con RDT. Se dividieron en dos grupos: grupo Pilocarpina (P), que recibió pilocarpina, antes y después de la RDT y el grupo no Pilocarpina (NP), que recibió RDT sin pilocarpina. La gammagrafia y la sialometría se realizaron antes de iniciar la RDT y durante un año de seguimiento. Se han obtenido los índices de captación y excreción de las glándulas parótidas y submaxilares. La medición del flujo salivar se realizó tras estimulación durante 5 minutos. Resultados: La captación y excreción de glándulas salivares disminuyó después de la RDT. No se encontraron diferencias significativas entre el grupo P y NP, aunque la captación parotidea muestra una tendencia a la recuperación funcional a los 12 meses en el grupo P, que no fue estadísticamente significativa. El flujo salivar disminuyó tras la RDT en ambos grupos y se encontró correlación (r = 0,8) entre el flujo salivar y la excreción salivar. Conclusión: La gammagrafía salivar y la sialometría nos han permitido evaluar la función salivar, demostrando que aunque la captación salivar mejora discretamente a los 12 meses tras la RDT en los pacientes tratados con pilocarpina, este tratamiento no parece prevenir la xerostomía secundaria a la RDT (AU)

[Usefulness of pilocarpine in the prevention of xerostomia in patients with head and neck cancer treated with radiotherapy. Assessment with gammagraphy and salivary flow]. / Utilidad de la pilocarpina como profiláctico de xerostomía en pacientes con cáncer de cabeza y cuello tratados con radioterapia. Valoración mediante gammagrafía y flujo salivar.

AIM: To assess the utility of salivary gland scintigraphy and salivary flow to quantify salivary function and to evaluate the usefulness of pilocarpine in the treatment of radiation-induced xerestomia in head and neck cancer patients. METHOD: Thirty two patients with head and neck tumor treated with radiotherapy (RDT) were studied. Patients were classified into two groups: pilocarpine group (P), that received prophylactic pilocarpine before RDT and during the first year after treatment. No pilocarpine group (NP) that received RDT without pilocarpine. Salivary gland scintigraphy and salivary flow were performed before RDT and during one year after treatment. Parotid and submaxillary uptake and excretion were calculated. Salivary flow after stimulation during five minutes was also obtained. RESULTS: Uptake and excretion in both salivary glands decreased after RDT. There were no statistical differences comparing P and NP groups (p < 0.001). However, in group P a trend to recovery was observed in parotid uptake values at 12 months after treatment, but it was not statistically significant. In both groups the salivary flow decreased after RDT and a good correlation (r = 0.8) between salivary flow and submaxillary excretion and parotid excretion was found. CONCLUSIONS: Salivary gland scintigraphy and salivary flow could be useful to evaluate salivary gland function in patients with head and neck irradiated tumors. Although better results on the salivary uptake at 12 months were noted, pilocarpine did not significantly improve salivary gland function.

[111In-pentetreotide in the study of tumors expressing somatostatin receptors]. / 111In-pentetreótida en el estudio de tumores que expresan receptores para la somatostatina.

UNLABELLED: The usefulness of 111In-pentetreotide scintigraphy in the diagnosis of neuroendocrine tumors was evaluated. MATERIAL AND METHOD: 39 patients with clinical or biochemical suspicion of neuroendocrine tumors were studied. 29 patients underwent surgery and diagnosis was confirmed by anatomopathology findings (7 mixed tumors, 6 carcinoids, 3 insulinomas, 3 pheocromocytomas, 2 glucagonomas, 2 medullary thyroid carcinomas, 1 gastrinoma and 5 metastatic lesions). In 10 patients who did not undergo surgery, the diagnostic criteria were based on a 6 month follow-up. 111In-pentetreotide scintigraphy and computed tomography (CT) were performed in all of the patients. RESULTS: The scintigraphy correctly detected 58% of the primary tumors while the CT was positive in only 45% of the cases. Both techniques detected metastasis in 5 patients. CONCLUSION: 111In-pentetreotide scintigraphy is a useful technique to diagnose those tumors that have somatostatin receptors. In our series, the sensitivity of this method was higher than the CT.

[Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carcinoma]. / Inmunogammagrafía con anticuerpos monoclonales anti-CEA y anti-TAG-72 en el diagnóstico del carcinoma colorrectal.

BACKGROUND: The purpose of nuclear medicine in the evaluation of colorectal carcinoma is to complete the current diagnostic protocol, by means of monoclonal antibodies (MoAb) against tumoral antigens labelled with radioactive isotopes and performing an immunoscintigraphy. PATIENTS AND METHODS: Immunoscintigraphies have been performed to 143 patients with colorectal carcinoma. Group I: antiCEA MoAb 99mTc-BW 431/26 (72 patients with 74 lesions, 48 primary tumors and 26 recurrences); group II: antiTAT-72 MoAb 111In-CYT-103 (71 patients with 75 lesions, 28 primary tumors and 47 recurrences). All positive images, not corresponding to physiological distribution of MoAb, have been considered as pathological. RESULTS: The sensitivity in the diagnosis of primary tumors in group I was worse than in group II (54.2% vs 66.7%). If rectum tumors were excluded, the sensitivity increased to 80% and 85.7%, respectively. In the suspicion of recurrences, if only lesions confirmed at surgery were considered, the sensitivity was 75% in group I and 89.7% in group II. The immunoscintigraphy has been the only technique able to diagnose recurrences in 4/23 cases from group I and 14/32 from group II. In liver, considering as metastases only hot images, the sensitivity is very low in group I (44.4%) and null in group II. No relationship has been found between tumour markers levels and the immunoscintigraphic result. CONCLUSIONS: Immunoscintigraphy is useful in patients with colorectal carcinoma, especially in the case of recurrences and it is a complementary technique to other diagnostic procedures.